1. Home
  2. Chat
  3. Everything You Need to Know about Pfizer's Covid Vaccine

Everything You Need to Know about Pfizer's Covid Vaccine

In the News

Image

How many doses of the vaccine has the UK bought?

+ UK has secured 40m doses, with 10m due by the end of the year

+ 800k doses available next week

+ Patients need two doses, so there are only enough doses for around a third of Britain

How long does it protect you for?

+ Regulators said there was evidence of 'partial immunity' just seven days after the first dose

+ The best immunity comes seven days after the second dose, which is given three weeks after the first

How will a vaccine be rolled out?

+ Nightingale Hospitals and sports stadiums have been prepared as sites for mass vaccination clinics

+ Matt Hancock: '50 hospitals across the country are already set up and waiting to receive the vaccine'

What are the advantages of this type of vaccine?

+ No actual virus is needed to create an mRNA vaccine

+ This means it can be produced much quicker

+ In theory, they can also be modified quickly if a virus develops mutations

Are there any downsides?

+ One downside is that mRNA vaccines need to be stored at ultra-cold temperatures

+ Pfizer's Covid vaccine must be stored at minus 70C — about four times colder than a household freezer

Are they safe?

+ All vaccines undergo rigorous testing and have oversight from experienced regulators

+ Some believe mRNA vaccines are safer for the patient

How much does it cost?

+ Pfizer/BioNTech is making its vaccine not-for-profit

+ The Moderna vaccine could cost about £28 per dose and the Pfizer candidate could cost around £15

+ The Oxford vaccine could be relatively cheap to produce

How has this come about so quickly?

+ Traditionally vaccines can take years to research and develop

+ The timetable for developing and approving a Covid vaccine has been condensed due to the coronavirus crisis

But won’t that mean that safety is compromised?

+ Safety checks have still been the same as for any new medicine

+ In most clinical trials, any issues are usually identified in the first three months – a period which has already lapsed

How are regulators acting so quickly?

+ Regulators have been carrying out 'rolling reviews'

+ This means regulators can start to look at scientific data earlier than they traditionally would do

Stevo1283
2 months ago
What do you think of this?
One of the UK's largest deal hunting communities

Join for free to get genuine deals, money saving advice and help from our friendly community

Kelsey, Tom
& Deepak
Founders
Founders of Latest Deals
We use cookies (e.g. personalisation, analytics, social media). Find out more.